FDA approval Lovastatin - Advicor clinical trails
Home       Treatment        Side Effects       Starshine       FDA Aproval

 

FDA approval for Lovastatin - Advicor

Lovastatin is used for lowering the cholesterol and it is preventing cardiovascular diseases. Brand name of the lovastatin is Advicor. It is in the class named statins. The Food and Drug administration based in US generally known as FDA has approved this lovastatin drug in august 16 in 2007. FDA has produced its approval for niacin extended release lovastatin tablets for the manufacturing company named KOS pharmaceuticals, Inc. The niacin extended release tablets are approved for the treatment of cholesterol and the members of the FDA realized the side effects of this lovastatin.

The FDA announced its detailed report after many researches and clinical trials. The members realized that the medicine is capable to treat some diseases and they also understand the side effects like myopathy and rhabdomyosis of this medicine. A myopathy patient will be subjected to muscle pain, tenderness, and weakness. The application number of the lovstatin is 21-249. The FDA reported that the usage of this medicine causes to serious skeletal diseases. The manufacturing companies are producing different types of tablets including 500 mg/20mg, 750mg/ 20mg, and 1000mg/ 20 mg.

These tablets are able to treat the primary hypercholesterolemia and mixed dyslipidemia. The FDA has approved the lovastatin for the treatment of TG lowering or HDL raising and LDL lowering. They have realized that the tablets are safe and effective. They identified the positive result of the medicine and nowadays the drugs are producing good sale.
 

Home       Treatment        Side Effects       Starshine       FDA Aproval